• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

An amino acid polymorphism in histidine-rich glycoprotein (HRG) explains 59% of the variance in plasma HRG levels.

作者信息

Hennis B C, Boomsma D I, van Boheemen P A, Engesser L, Kievit P, Dooijewaard G, Kluft C

机构信息

Gaubius Laboratory TNO-PG, Leiden, The Netherlands.

出版信息

Thromb Haemost. 1995 Dec;74(6):1497-50.

PMID:8772227
Abstract

A pedigree-based maximum likelihood method developed by Lange et al. (12) was used to study the contribution of a newly defined di-allelic polymorphism in histidine-rich glycoprotein (HRG) to the plasma levels of HRG. In four families (n = 99) and 20 volunteers we found a heritability of 70%, an age effect of 3% and an effect of individual environmental factors of 27%. These results are remarkably similar to the results found in a previous parent-twin study in which a heritability of 69% and an effect of random environment of 31% was found. The overall genetic influence in the present study can be subdivided into an effect of 59% by the HRG phenotype and 11% by residual genetic factors. The influence of the HRG phenotype of 59% can entirely be explained by adding up the effect of the two alleles that make up the phenotype. These results indicate a codominant inheritance pattern of HRG levels in which the genetic influences can almost completely be ascribed to the additive effect of the di-allelic HRG locus whereas only a small part is due to other loci.

摘要

相似文献

1
An amino acid polymorphism in histidine-rich glycoprotein (HRG) explains 59% of the variance in plasma HRG levels.
Thromb Haemost. 1995 Dec;74(6):1497-50.
2
Identification and genetic analysis of a common molecular variant of histidine-rich glycoprotein with a difference of 2kD in apparent molecular weight.富含组氨酸糖蛋白常见分子变体的鉴定及基因分析,其表观分子量相差2kD。
Thromb Haemost. 1995 Dec;74(6):1491-6.
3
A parent-twin study of plasma levels of histidine-rich glycoprotein (HRG).一项关于富含组氨酸糖蛋白(HRG)血浆水平的亲子-双胞胎研究。
Thromb Haemost. 1993 Nov 15;70(5):848-51.
4
Hereditary increase of plasma histidine-rich glycoprotein associated with abnormal heparin binding (HRG Eindhoven).与异常肝素结合相关的血浆富含组氨酸糖蛋白遗传性增加(埃因霍温HRG)
Thromb Haemost. 1993 Dec 20;70(6):894-9.
5
The histidin-rich glycoprotein Pro186/Ser polymorphism is not related to myocardial infarction in the ECTIM study.在ECTIM研究中,富含组氨酸的糖蛋白Pro186/Ser多态性与心肌梗死无关。
Thromb Haemost. 1998 Feb;79(2):359-61.
6
Histidine-rich glycoprotein (HRG) Tokushima 2: novel HRG deficiency, molecular and cellular characterization.富含组氨酸糖蛋白(HRG)德岛2型:新型HRG缺乏症,分子与细胞特征
Thromb Haemost. 2000 Oct;84(4):675-9.
7
A specific allele of the histidine-rich glycoprotein (HRG) locus is linked with elevated plasma levels of HRG in a Dutch family with thrombosis.
Br J Haematol. 1995 Apr;89(4):845-52. doi: 10.1111/j.1365-2141.1995.tb08423.x.
8
Congenital histidine-rich glycoprotein deficiency.
Thromb Haemost. 1993 Aug 2;70(2):263-5.
9
Modified crossed immunoelectrophoresis to study with whole plasma the reversible complex formation of histidine-rich glycoprotein with plasminogen.改良交叉免疫电泳法用于研究富含组氨酸糖蛋白与纤溶酶原在全血浆中的可逆复合物形成。
Thromb Haemost. 1988 Dec 22;60(3):411-4.
10
Histidine-rich glycoprotein binds to human IgG and C1q and inhibits the formation of insoluble immune complexes.富含组氨酸的糖蛋白与人IgG和C1q结合,并抑制不溶性免疫复合物的形成。
Biochemistry. 1997 Jun 3;36(22):6653-62. doi: 10.1021/bi962573n.

引用本文的文献

1
Genome-wide association and linkage analysis of histidine-rich glycoprotein identifies common variants associated with plasma histidine-rich glycoprotein concentrations.富含组氨酸糖蛋白的全基因组关联和连锁分析确定了与血浆富含组氨酸糖蛋白浓度相关的常见变异。
Res Pract Thromb Haemost. 2025 Jun 24;9(5):102955. doi: 10.1016/j.rpth.2025.102955. eCollection 2025 Jul.